SCHEMBL6424699

SCHEMBL6424699

COCCOCCOCCC(=O)OCn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 2/20 0.44
PRKACG P22612 2/20 0.44
PRKACB P22694 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424161 0.87 PIM1 (0.47)
SCHEMBL6424296 0.85 CCNE2 (0.50)
SCHEMBL6948330 0.85 CCNE2 (0.54)
SCHEMBL6427037 0.81 CCNE2 (0.57)
SCHEMBL6425680 0.79 GSK3B (0.49)
Enmd-981693 SCHEMBL608128 0.79 CCNE2 (0.69)
Enmd-981693 SCHEMBL29350364 0.79 CCNE2 (0.69)
SCHEMBL6956384 0.77 CCNT1 (0.46)
SCHEMBL6425419 0.76 GSK3B (0.45)
Hydrochloric Acid SCHEMBL6425416 0.76 GSK3B (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242408-B1 SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION HOFFMANN LA ROCHE (CH) 2005-10-12 EP claimed
US-6313143-B1 USEFUL IN THERAPY OF CELL PROLIFERATIVE DISORDERS SUCH AS CANCER HOFFMANN-LA ROCHE INC. 2001-11-06 US claimed
EP-1242408-B1 SUBSTITUTED BISINDOLYLMALEIMIDES FOR THE INHIBITION OF CELL PROLIFERATION HOFFMANN LA ROCHE (CH) 2005-10-12 EP disclosed
US-6313143-B1 USEFUL IN THERAPY OF CELL PROLIFERATIVE DISORDERS SUCH AS CANCER HOFFMANN-LA ROCHE INC. 2001-11-06 US disclosed